SEC Form 4 · accession 0001127602-16-063340
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Kuntz
Officer — SrVP & Chief Scien, Clin, Reg
Period of report
Sep 26, 2016
Accepted (ET)
Sep 28, 2016 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Sep 26, 2016 | M | 30,624 | $35.92 | A | 149,425 | D | |
| Ordinary SharesF1 | Sep 26, 2016 | S | 25,199 | $86.67 | D | 124,226 | D | |
| Ordinary SharesF2 | Sep 27, 2016 | S | 17,141 | $86.696 | D | 107,085 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $35.92 | Sep 26, 2016 | M | 30,624 | D | — | Aug 3, 2019 | Ordinary Shares | 30,624 | 0 | D |
Explanation of responses
- F1The price is a weighted average price. These shares were sold in multiple transactions in prices ranging from $86.57 to $86.735, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote in this Form 4.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.675 to $86.725, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3This option to purchase 30,624 New Medtronic ordinary shares for $35.92 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 30,624 Medtronic common stock shares for $35.92 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.